KPRX · Kiora Pharmaceuticals Inc
$2.57
+0.00 (+0.00%)
At close · Jul 29
Going-concern doubt
— flagged May 8, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our Condensed Consolidated Financial Statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities or any other adjustments that might be necessary should we be unable to continue as a going concern.”View the 10-Q filed May 8, 2026
Market Cap
$11.39M
Shares
4.43M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-04-21 | New | Pharmaceuticals | $5,000,000 | $5,000,000 | 06b |
| 2024-02-14 | New | Pharmaceuticals | $15,000,000 | $15,000,000 | 06b |
| 2023-02-17 | New | Pharmaceuticals | $10,000,000 | $0 | 06b |
| 2023-02-17 | New | Pharmaceuticals | $200,000 | $200,000 | 06b |
| 2021-11-04 | New | Pharmaceuticals | Indefinite | $67,258 | 06b |
| 2021-08-23 | New | Pharmaceuticals | $10,750,013 | $10,750,013 | 06b |
| 2021-01-21 | New | Pharmaceuticals | $8,000,003 | $8,000,003 | 06b |
| 2021-01-04 | New | Pharmaceuticals | Indefinite | $3,203,083 | 06b |
| 2020-01-15 | New | Pharmaceuticals | Indefinite | $0 | 06b |
Showing 1–9 of 9 filings